Schistosomiasis project gets $1.15M boost from Gates Foundation

08/26/2013 | Pharmaceutical Business Review Online

An international public-private partnership that aims to develop a pediatric treatment for schistosomiasis, or bilharzia, received a $1.15 million grant from the Bill & Melinda Gates Foundation. Members of the consortium include Astellas Pharma, Merck KGaA and the Swiss Tropical and Public Health Institute.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN